Case 22-2010: An 87-year-old woman with dementia and a seizure

New England Journal of Medicine

Volumn 363, Issue 4, 2010, Pages 373-

  Greenberg, Steven M ^a,b   Rapalino, Otto ^a,b   Frosch, Matthew P ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; FOSPHENYTOIN SODIUM; HYDRALAZINE; METHYLPREDNISOLONE; NICARDIPINE; PHENYTOIN; PRAZOSIN;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN INFARCTION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DEMENTIA; DIFFERENTIAL DIAGNOSIS; EMERGENCY HEALTH SERVICE; FEMALE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SNORING; SOMNOLENCE; TONIC CLONIC SEIZURE; VASCULAR AMYLOIDOSIS; BRAIN; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; FATALITY; LUNG; PATHOLOGY; RADIOGRAPHY; SEIZURE;

AGED, 80 AND OVER; BRAIN; CEREBRAL AMYLOID ANGIOPATHY; CEREBRAL INFARCTION; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; FEMALE; HUMANS; LUNG; SEIZURES;

EID: 77954823464     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcpc1004364     Document Type: Article

References (33)

1. Viswanathan A, Chabriat H. Cerebral microhemorrhage. Stroke 2006;37:550-5.
2. Greenberg SM, Vernooij MW, Cordonnier C, et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol 2009;8:165-74.
3. Blitstein MK, Tung GA. MRI of cerebral microhemorrhages. AJR Am J Roentgenol 2007;189:720-5.
4. Topuz S, Kalelioǧlu I, Iyibozkurt AC, et al. Cranial imaging spectrum in hypertensive disease of pregnancy. Clin Exp Obstet Gynecol 2008;35:194-7.
5. Pettersen JA, Sathiyamoorthy G, Gao FQ, et al. Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook Dementia Study. Arch Neurol 2008;65:790-5.
6. Eng JA, Frosch MP, Choi K, Rebeck GW, Greenberg SM. Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol 2004;55:250-6. (Pubitemid 38167002)
7. Yamada M. Cerebral amyloid angiopathy: an overview. Neuropathology 2000;20:8-22.
8. Sarazin M, Amarenco P, Mikol J, Dimitri D, Lot G, Bousser MG. Reversible leukoencephalopathy in cerebral amyloid angiopathy presenting as subacute dementia. Eur J Neurol 2002;9:353-8.
9. Alcalay RN, Smith EE. MRI showing white matter lesions and multiple lobar microbleeds in a patient with reversible encephalopathy. J Neuroimaging 2009;19:89-91.
10. Kinnecom C, Lev MH, Wendell L, et al. Course of cerebral amyloid angiopathy-related inflammation. Neurology 2007;68:1411-6.
11. Liem MK, Lesnik Oberstein SA, Haan J, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: progression of MR abnormalities in prospective 7-year follow-up study. Radiology 2008;249:964-71.
12. Ay H, Sahin G, Saatci I, Söylemezoǧlu F, Saribas O. Primary angiitis of the central nervous system and silent cortical hemorrhages. AJNR Am J Neuroradiol 2002;23:1561-3. (Pubitemid 35154999)
13. Arias M, Osorio X, Dapena D, Arias-Rivas S, Vazquez F. Recurrent leukoencephalopathy with microhemorrhages: gradient-echo MRI study diagnostic value in CNS primary angiitis. Mult Scler 2008;14:1139-41.
14. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44.
15. Vernooij MW, Ikram MA, Tanghe HL, et al. Incidental findings on brain MRI in the general population. N Engl J Med 2007;357:1821-8.
16. Cordonnier C, van der Flier WM, Sluimer JD, Leys D, Barkhof F, Scheltens P. Prevalence and severity of microbleeds in a memory clinic setting. Neurology 2006;66:1356-60.
17. Rosand J, Muzikansky A, Kumar A, et al. Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy. Ann Neurol 2005;58:459-62.
18. Amatniek JC, Hauser WA, DelCastillo-Castaneda C, et al. Incidence and predictors of seizures in patients with Alzheimer's disease. Epilepsia 2006;47:867-72.
19. Rao SC, Dove G, Cascino GD, Petersen RC. Recurrent seizures in patients with dementia: frequency, seizure types, and treatment outcome. Epilepsy Behav 2009;14:118-20.
20. Oh U, Gupta R, Krakauer JW, Khandji AG, Chin SS, Elkind MS. Reversible leukoencephalopathy associated with cerebral amyloid angiopathy. Neurology 2004;62:494-7. (Pubitemid 38200871)
21. Scolding NJ, Joseph F, Kirby PA, et al. Aβ-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain 2005;128:500-15.
22. Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol 2008;29:1036-42.
23. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500.
24. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003;348:1215-22.
25. Haglund M, Englund E. Cerebral amyloid angiopathy, white matter lesions and Alzheimer encephalopathy - a histopathological assessment. Dement Geriatr Cogn Disord 2002;14:161-6.
26. Kimberly WT, Gilson A, Rost NS, et al. Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy. Neurology 2009;72:1230-5.
27. Nicoll JA, Wilkinson D, Holmes C, Steart P, Markham H, Weller RO. Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat Med 2003;9:448-52.
28. Orgogozo JM, Gilman S, Dartigues JF, et al. Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization. Neurology 2003;61:46-54.
29. Salloway S, Sperling R, Gilman S, et al. A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology 2009;73:2061-70.
30. Greenberg SM, Vonsattel JP. Diagnosis of cerebral amyloid angiopathy: sensitivity and specificity of cortical biopsy. Stroke 1997;28:1418-22.
31. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59.
32. Hyman BT, Trojanowski JQ. Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 1997;56:1095-7.
33. Vernooij MW, van der Lugt A, Ikram MA, et al. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology 2008;70:1208-14.